1. Home
  2. LIDR vs NXL Comparison

LIDR vs NXL Comparison

Compare LIDR & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • NXL
  • Stock Information
  • Founded
  • LIDR 2013
  • NXL 2010
  • Country
  • LIDR United States
  • NXL United States
  • Employees
  • LIDR N/A
  • NXL N/A
  • Industry
  • LIDR Auto Parts:O.E.M.
  • NXL Medical Specialities
  • Sector
  • LIDR Consumer Discretionary
  • NXL Health Care
  • Exchange
  • LIDR Nasdaq
  • NXL Nasdaq
  • Market Cap
  • LIDR 9.8M
  • NXL 10.0M
  • IPO Year
  • LIDR N/A
  • NXL 2022
  • Fundamental
  • Price
  • LIDR $1.10
  • NXL $3.23
  • Analyst Decision
  • LIDR Hold
  • NXL Hold
  • Analyst Count
  • LIDR 1
  • NXL 1
  • Target Price
  • LIDR N/A
  • NXL N/A
  • AVG Volume (30 Days)
  • LIDR 547.8K
  • NXL 533.6K
  • Earning Date
  • LIDR 11-12-2024
  • NXL 11-08-2024
  • Dividend Yield
  • LIDR N/A
  • NXL N/A
  • EPS Growth
  • LIDR N/A
  • NXL N/A
  • EPS
  • LIDR N/A
  • NXL N/A
  • Revenue
  • LIDR $225,000.00
  • NXL $162,078.00
  • Revenue This Year
  • LIDR N/A
  • NXL $56.86
  • Revenue Next Year
  • LIDR $2,650.00
  • NXL $167.44
  • P/E Ratio
  • LIDR N/A
  • NXL N/A
  • Revenue Growth
  • LIDR N/A
  • NXL 26.00
  • 52 Week Low
  • LIDR $0.78
  • NXL $0.25
  • 52 Week High
  • LIDR $5.15
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 48.53
  • NXL 42.43
  • Support Level
  • LIDR $1.07
  • NXL $3.25
  • Resistance Level
  • LIDR $1.64
  • NXL $4.49
  • Average True Range (ATR)
  • LIDR 0.15
  • NXL 0.35
  • MACD
  • LIDR 0.01
  • NXL -0.17
  • Stochastic Oscillator
  • LIDR 18.18
  • NXL 7.26

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: